Chosun Ilbo reports Novo has raised its factory investment tenfold, to 13.4 trillion won, as demand for obesity treatments keeps climbing.
Recap by typeshit. Full story at 조선일보.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Generic makers gain ground as another layer of semaglutide protection falls, per Life Sciences IP Review. Full story is behind a paywall.
The biotech has stopped a weight loss maintenance trial of its weekly GLP-1 pill. FirstWord Pharma has the details on the decision.
Loading…